CIK 0001401667 · Accelerated filer<br>Smaller reporting company
PUMA BIOTECHNOLOGY, INC.
Sign in to watch- Ticker
- PBYI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770683487
- Phone
- (424) 248-6500
- Business address
- 10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES, CA
- Former names
- INNOVATIVE ACQUISITIONS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $612,494
- in 2 filings, $612K under 10b5-1 plans
Net −$612,494. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-18 | AUERBACH ALAN H President and CEO | Grant or award · Stock Option (Right to Buy) | +227,474 | 227,474 | ||
| 2026-02-18 | HUNT DOUGLAS M See Remarks | Grant or award | +49,394 | 205,301 | ||
| 2026-02-18 | HUNT DOUGLAS M See Remarks | Grant or award · Stock Option (Right to Buy) | +70,321 | 70,321 | ||
| 2026-02-18 | NOUGUES MAXIMO F Chief Financial Officer | Grant or award | +46,739 | 240,023 | ||
| 2026-02-18 | NOUGUES MAXIMO F Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +66,541 | 66,541 | ||
| 2026-01-07 | AUERBACH ALAN H President and CEO | Sale 10b5-1 | −18,012 | $5.88 | $106K | 7,145,951 |
| 2026-01-07 | HUNT DOUGLAS M See Remarks | Sale 10b5-1 | −5,014 | $5.88 | $29K | 155,907 |
| 2026-01-07 | NOUGUES MAXIMO F Chief Financial Officer | Sale 10b5-1 | −6,405 | $5.88 | $38K | 193,284 |
| 2026-01-06 | AUERBACH ALAN H President and CEO | Sale 10b5-1 | −16,938 | $5.84 | $99K | 7,163,963 |
| 2026-01-06 | HUNT DOUGLAS M See Remarks | Sale 10b5-1 | −3,973 | $5.84 | $23K | 160,921 |
| 2026-01-06 | NOUGUES MAXIMO F Chief Financial Officer | Sale 10b5-1 | −4,540 | $5.84 | $27K | 199,689 |
| 2025-11-11 | MILLER MICHAEL PATRICK Director | Sale | −20,000 | $4.86 | $97K | 54,000 |
| 2025-07-18 | Cesano Alessandra Director | Sale 10b5-1 | −27,000 | $3.37 | $91K | 41,850 |
| 2025-07-09 | NOUGUES MAXIMO F Chief Financial Officer | Sale 10b5-1 | −3,935 | $3.54 | $14K | 204,229 |
| 2025-07-09 | HUNT DOUGLAS M See Remarks | Sale 10b5-1 | −3,443 | $3.54 | $12K | 164,894 |
| 2025-07-09 | AUERBACH ALAN H President and CEO | Sale 10b5-1 | −21,580 | $3.54 | $76K | 7,180,901 |
| 2025-07-08 | NOUGUES MAXIMO F Chief Financial Officer | Sale 10b5-1 | −5,587 | $3.53 | $20K | 208,164 |
| 2025-07-08 | HUNT DOUGLAS M See Remarks | Sale 10b5-1 | −4,374 | $3.53 | $15K | 168,337 |
| 2025-07-08 | AUERBACH ALAN H President and CEO | Sale 10b5-1 | −25,592 | $3.53 | $90K | 7,202,481 |
| 2025-06-13 | WILSON TROY EDWARD Director | Sale 10b5-1 | −10,800 | $3.40 | $37K | 43,550 |
Page 2 of 7 · 137 trades